支架植入术后的双重抗血小板治疗——回复 - Suppr

Suppr

超能文献

Dual antiplatelet therapy after stent implantation--reply.

作者信息

Feres Fausto, Costa Ricardo A, Bhatt Deepak L

机构信息

Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil.

Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA. 2014 Apr 9;311(14):1446-7. doi: 10.1001/jama.2014.2107.

DOI:10.1001/jama.2014.2107

PMID:24715082

Abstract

摘要

相似文献

Dual antiplatelet therapy after stent implantation--reply.支架植入术后的双重抗血小板治疗——回复

JAMA. 2014 Apr 9;311(14):1446-7. doi: 10.1001/jama.2014.2107.

Dual antiplatelet therapy after stent implantation.支架植入术后的双联抗血小板治疗。

JAMA. 2014 Apr 9;311(14):1446. doi: 10.1001/jama.2014.2092.

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.载有佐他莫司的药物洗脱支架置入后双联抗血小板治疗 3 个月与 12 个月：OPTIMIZE 随机试验。

JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.

Antiplatelet therapy: DAPT for 3 months is sufficient.抗血小板治疗：3个月的双联抗血小板治疗就足够了。

Nat Rev Cardiol. 2014 Jan;11(1):3. doi: 10.1038/nrcardio.2013.175. Epub 2013 Nov 19.

Less may be more: insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry.少或许就是多：来自MATRIX注册研究的关于药物洗脱支架植入术后双联抗血小板治疗时长的见解

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):417-9. doi: 10.1002/ccd.24571.

Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy.与第二类错误的亲密接触：评估长期双联抗血小板治疗的风险和益处

Eur Heart J. 2015 May 21;36(20):1216-8. doi: 10.1093/eurheartj/ehv082. Epub 2015 Mar 21.

A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.一项随机、双盲、多中心对比研究，旨在比较三联抗血小板治疗与双联抗血小板治疗在减少长病变药物洗脱支架置入后再狭窄方面的疗效：来自 DECLARE-LONG II 试验（西洛他唑治疗可降低长病变患者药物洗脱支架置入后晚期再狭窄）的结果。

J Am Coll Cardiol. 2011 Mar 15;57(11):1264-70. doi: 10.1016/j.jacc.2010.10.035.

Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?药物洗脱支架植入术后的双联抗血小板治疗：是时候放松缰绳了吗？

J Am Coll Cardiol. 2012 Oct 9;60(15):1349-51. doi: 10.1016/j.jacc.2012.08.003. Epub 2012 Sep 19.

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.接受支架植入后 6 或 24 个月双抗血小板治疗的患者临床特征对缺血和出血结局的影响：来自 PRODIGY（评价支架内内膜增生后延长双联抗血小板治疗）试验的预先指定分析。

Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25.

Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。

JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

引用本文的文献

Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.冠状动脉支架置入术后双联抗血小板治疗延长超过12个月的急性冠状动脉综合征患者的长期预后

Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1176-1184. doi: 10.1002/ccd.26831. Epub 2016 Nov 10.

Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.冠状动脉支架置入术后氯吡格雷使用超过12个月的糖尿病患者的长期预后

J Am Coll Cardiol. 2015 Sep 8;66(10):1091-101. doi: 10.1016/j.jacc.2015.06.1339.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验